South African business group lobbies vaccine focus on senior citizens

A business lobby group in South Africa has reportedly called on the government to shift the focus of its vaccine program on the elderly as well as the vulnerable, to avoid hospitals being flooded with patients from a third COVID-19 wave.

Countries urge vaccine makers to share vaccine know-how and blueprints

Throughout Southeast Asia and Africa, several aid groups and governments agencies are joining the World Health Organization’s call for pharmaceutical enterprises to share their respective COVID-19 vaccine patent information in an effort to address the yawning global vaccine shortfall more e

Study suggests Pfizer vaccine might be less effective in obese people

Data from a recent study suggests that the Pfizer/BioNTech COVID-19 vaccine might be less effective for people that are obese. Researchers in Italy have discovered that, as compared to healthy individuals, obese healthcare workers were able to produce just about half the total amount of antibodie

South Africa to invest $712Mn for commencing its mass vaccination drive

South Africa is nearing plans to inject $712 million to vaccinate 67% of its population as to control the spread of the coronavirus in the country as well as to revive the economy which had faced a slopping decline of 7.2% last year.

South Africa was already in the midst of an economy rece

Moderna to start testing vaccine which fights the South Africa strain

Renowned American biotech firm, Moderna, has reportedly announced that it is currently working with a number of government scientists in South Africa to study the efficacy of an experimental booster dose designed specifically to target the South African strain of the coronavirus.

The biote

Cartesian Therapeutics initiates Phase 2 Trial of multiple myeloma therapy

Driven by the need to develop an effective frontline cell therapy treatment for multiple myeloma, Cartesian Therapeutics, a clinical-stage biopharmaceutical company specializing in mRNA-engineered cell therapy, has announced the initiation of a Phase 2a clinical trial of Descartes-11, a new mRNA